These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22500870)

  • 1. Serotype replacement after pneumococcal vaccination.
    DiNubile MJ
    Lancet; 2012 Apr; 379(9824):1388; author reply 1388-9. PubMed ID: 22500870
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotype replacement after pneumococcal vaccination.
    Mulholland K; Satzke C
    Lancet; 2012 Apr; 379(9824):1387; author reply 1388-9. PubMed ID: 22500869
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotype replacement after pneumococcal vaccination.
    Hausdorff WP; Van Dyke MK; Van Effelterre T
    Lancet; 2012 Apr; 379(9824):1387-8; author reply 1388-9. PubMed ID: 22500868
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotype replacement in invasive pneumococcal disease: where do we go from here?
    Hanage WP
    J Infect Dis; 2007 Nov; 196(9):1282-4. PubMed ID: 17922390
    [No Abstract]   [Full Text] [Related]  

  • 5. Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement.
    Hausdorff WP; Hanage WP
    Hum Vaccin Immunother; 2016; 12(2):358-74. PubMed ID: 26905681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and serotype coverage: key criteria for pneumococcal vaccines for adults.
    Grabenstein JD
    Clin Infect Dis; 2012 Jul; 55(2):255-8. PubMed ID: 22495543
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pneumococcal vaccination and serotype replacement: Do we need new vaccination concepts?].
    Kenzel S; Hufnagel M; Berner R; Henneke P
    Dtsch Med Wochenschr; 2010 Jun; 135(23):1198-200. PubMed ID: 20480453
    [No Abstract]   [Full Text] [Related]  

  • 8. Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine.
    Hoberman A; Paradise JL; Shaikh N; Greenberg DP; Kearney DH; Colborn DK; Rockette HE; Kurs-Lasky M; McEllistrem MC; Zoffel LM; Balentine TL; Barbadora KA; Wald ER
    Clin Pediatr (Phila); 2011 Feb; 50(2):114-20. PubMed ID: 21098526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.
    Beall B
    Expert Rev Vaccines; 2007 Jun; 6(3):297-300. PubMed ID: 17542743
    [No Abstract]   [Full Text] [Related]  

  • 10. Why it is still important that countries know the burden of pneumococcal disease.
    Prato R; Tafuri S; Fortunato F; Martinelli D
    Hum Vaccin; 2010 Nov; 6(11):918-21. PubMed ID: 21045538
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges to pneumococcal vaccine in India.
    Kanungo R
    Indian J Med Microbiol; 2013; 31(1):1-2. PubMed ID: 23508420
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
    Moraga-Llop FA
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotype 19A Streptococcus pneumoniae among Indian isolates is a cause for concern.
    Shariff M; Zahoor S; Deb M
    Indian J Med Microbiol; 2012; 30(1):112. PubMed ID: 22361777
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination against invasive pneumococcal disease in Saudi Arabia: where do we stand?
    Frayha HH; Al Mazrou YY
    Ann Saudi Med; 2005; 25(2):90-3. PubMed ID: 15977683
    [No Abstract]   [Full Text] [Related]  

  • 15. The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation.
    Black S
    Pediatr Infect Dis J; 2010 Apr; 29(4):301-3. PubMed ID: 19935444
    [No Abstract]   [Full Text] [Related]  

  • 16. Pneumococcal serotype diversity among adults in various countries, influenced by pediatric pneumococcal vaccination uptake.
    Grabenstein JD; Weber DJ
    Clin Infect Dis; 2014 Mar; 58(6):854-64. PubMed ID: 24344141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
    Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination.
    Rückinger S; von Kries R; Reinert RR; van der Linden M; Siedler A
    Vaccine; 2008 Jul; 26(32):3984-6. PubMed ID: 18495301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotype-specific problems associated with pneumococcal conjugate vaccination.
    Hanage WP
    Future Microbiol; 2008 Feb; 3(1):23-30. PubMed ID: 18230031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.
    Miller E; Andrews NJ; Waight PA; Slack MP; George RC
    Lancet Infect Dis; 2011 Oct; 11(10):760-8. PubMed ID: 21621466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.